NewEdge Advisors’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.6K Hold
400
﹤0.01% 3380
2025
Q1
$5.44K Buy
+400
New +$5.44K ﹤0.01% 3281